Christina Schwarz

Representative Matters

• Represented Novartis in Novartis v. Breckenridge, West-Ward and Par (Zortress® (everolimus) for kidney and liver transplants) (D. Del., Fed. Cir., PTAB-IPR)
• Represented Novartis in Novartis v. West-Ward (Afinitor® (everolimus) for renal cell carcinoma and pancreatic neuroendocrine tumors) (D. Del., Fed. Cir., PTAB-IPR)
• Represented Novartis in Novartis v. Par (Afinitor® (everolimus) for breast cancer) (D. Del.)
• Represented Novartis in Novartis v. Breckenridge (Afinitor® (everolimus) for renal cell carcinoma, renal angiomyolipoma, and tuberous sclerosis complex with subependymal giant cell astrocytoma) (D. Del., PTAB-IPR)
• Represented Novartis in Novartis v. Mylan (Afinitor® Disperz (everolimus) for tuberous sclerosis complex with subependymal giant cell astrocytoma) (D. Del.)

Representative Clients

• Genzyme
• Gilead
• Novartis
• Warner Chilcott
  
   

Education

• J.D. University of Western Ontario 2007
• M.Sc. Organic Chemistry University of Toronto 2004
• B.Sc. Immunology University of Toronto 2002

Bar Admissions

• New York
• U.S. Patent and Trademark Office
• Ontario, Canada

Court Admissions

• U.S. Court of Appeals for the Federal Circuit
• U.S. District Court for the Eastern District of New York
• U.S. District Court for the Southern District of New York

• Legal 500, Patent Litigation – Full Coverage, 2021
• LMG Life Sciences, Life Sciences Star, 2019 – 2020
• Super Lawyers, Intellectual Property Litigation, New York Metro, 2015 – 2018